Representatives Mikie Sherrill (D-NJ) https://sherrill.house.gov, Mike Levin (D-CA) https://levin.house.gov, and Abigail Spanberger (D-VA) https://spanberger.house.gov calling for an investment in biomedical research, have introduced the “Biomedical Innovation Expansion Act of 2019”.
The bill would provide:
- $10 billion over the next ten years at NIH to support new scientific research related to antibiotic resistance and rare diseases
- $3 billion for the “Precision Medicine Initiative” which includes the “All of US Research Program” https://allofus.nih.gov to build a diverse database to inform thousands of studies on a variety of health conditions
- $2.9 billion for the “Brain Research Advancing Innovative Neuro-technologies” (BRAIN) initiative and the goals set out in BRAIN 2025 https://braininitiative.nih.gov-strategic-planning/brain-2015-report which sets out a goal to gain insight into how the nervous system functions in health and disease
- $1.6 billion towards combating antimicrobial and antibiotic resistance which WHO https://www.who.int warns is one of the top ten threats to global health
- $15 billion for the “Beau Biden Cancer Moonshot” https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative to continue to accelerate cancer research
- $758 million to support research on the several thousands of rare diseases currently without a treatment
- $220 million toward the “Regenerative Medicine Innovation Project” https://nih.gov/research-training/medical-research-initiatives/rmi carried out in coordination with FDA https://fda.gov to advance the development of safe and effective regenerative medicine innovations using adult stem cells